Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hims & Hers Health Inc.

27.23
+0.28001.04%
Pre-market: 26.82-0.4100-1.51%06:54 EDT
Volume:18.50M
Turnover:490.65M
Market Cap:6.05B
PE:51.16
High:27.44
Open:25.16
Low:25.16
Close:26.95
Loading ...

3 High Growth Companies Insiders Are Eager To Hold

Simply Wall St.
·
18 Apr

Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers

StockStory
·
17 Apr

Robinhood, AppLovin, Hims & Hers Health, Sleep Number, and Covenant Logistics Shares Plummet, What You Need To Know

StockStory
·
17 Apr

Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it

Zacks
·
16 Apr

Press Release: Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025

Dow Jones
·
15 Apr

Hims & Hers Health Inc : Jefferies Raises Target Price to $25 From $21

THOMSON REUTERS
·
12 Apr

Hims & Hers Health Is Maintained at Hold by Truist Securities

Dow Jones
·
10 Apr

Truist Cuts Price Target on Hims & Hers Health to $33 From $39, Keeps Hold Rating

MT Newswires Live
·
10 Apr

PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know

StockStory
·
10 Apr

Pre-Bell|U.S. Futures Pare Declines; Tesla and Alibaba Plunge 7%; Nvidia Sinks 5%; Apple Drops 4%

Tiger Newspress
·
07 Apr

Top Growth Companies With Insider Ownership In April 2025

Simply Wall St.
·
07 Apr

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

Dow Jones
·
05 Apr

Hims & Hers Health (NYSE:HIMS) Rises 5% Over Last Quarter Following Strong 2024 Earnings

Simply Wall St.
·
05 Apr

Analysts Stay Cautious on HIMS Stock amid Core Business Uncertainty

TipRanks
·
03 Apr

‘Hold the Phone,’ Says Morgan Stanley on Hims & Hers Health Stock (HIMS)

TIPRANKS
·
03 Apr

3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes

Zacks
·
03 Apr

Hims & Hers Betting on FDA Loophole to Keep Selling Compounded Medications -- Market Talk

Dow Jones
·
03 Apr

Hims & Hers Liraglutide Launch Could Drive More Growth Than Zepbound -- Market Talk

Dow Jones
·
03 Apr

Hims & Hers Zepbound Offering Won't Bring Needed Sales Boom, Analysts Say -- Analysis

Dow Jones
·
03 Apr

Hims & Hers Health's Launch of Liraglutide on Telehealth Platform Seen as 'Incrementally Positive,' Says Truist Securities

MT Newswires Live
·
02 Apr